CVS Caremark (CVS) Falls 20% On Cautious Comments on PBM From Call
More News related to CVS
- The Brualdi Law Firm, P.C. Announces Class Action Lawsuit Against CVS Caremark Corporation
- Humana and CVS Caremark's MinuteClinic Expand Member Access to Convenient Quality Care
- MinuteClinic Opens First Retail Clinic in Washington, D.C. at CVS/pharmacy Store in Northeast
- Brower Piven Encourages Investors Who Have Losses in Excess of $300,000 From Investment in CVS Caremark Corporation to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsui
- CVS/pharmacy Kicks Off Annual Thanks and Giving(R) Campaign for the St. Jude Children's Research Hospital
More News related to Hot List
- Bank of America (BAC) Paying Back All $45 Billion in TARP
- Bank of America (BAC) will raise capital in order to pay back $45B in TARP
- Sigma Designs (SIGM) Misses Street's Q3 Views
- GM CEO Fritz Henderson Steps Down
- Hemispherx (HEB) Falls 30% as FDA Recommends Another Ampligen Study, Says Can't Approve Application in Present Form
Shares of CVS Caremark (NYSE: CVS) are falling following negative comments from the conference call. Shares are down nearly 20%
CVS said $3.7 billion in contract losses in the quarter. Lost more in PBM business than expected. PBM margin will fall 10% in 2010.
Related Categories
GuidanceHot List
Trader Talk
Stocks Mentioned
-0.07Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
